DuPont de Nemours, Inc.
Business
DuPont de Nemours is a advanced solutions provider serving healthcare, water, construction, and industrial markets with high-performance products, components, and technologies. Key offerings include medical packaging and device components (TYVEK®, TYCHEM®), water filtration and purification systems (AMBERLITE™, FILMTEC™), building envelope solutions (STYROFOAM™, CORIAN®), and industrial engineered components (Vespel®, MOLYKOTE®, Cyrel®). The company operates through two reportable segments: Healthcare & Water Technologies and Diversified Industrials, with manufacturing in approximately 20 countries and subsidiaries in about 50 countries worldwide.
Summary from 10-K filed 2026-02-17
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 6,849 | 6,719 | 6,614 | 13,017 | 12,566 | |
| Cost of sales | 4,486 | 4,499 | 4,442 | 8,402 | 7,971 | |
| Research and development expenses | 193 | 203 | 192 | 536 | 557 | |
| Selling, general and administrative expenses | 1,019 | 976 | 891 | 1,467 | 1,602 | |
| Amortization of intangibles | 291 | 294 | 267 | 590 | 566 | |
| Restructuring and asset related charges - net | 151 | 57 | 99 | 155 | 50 | |
| Goodwill impairment charge | 0 | 0 | 668 | 0 | 0 | |
| Acquisition, integration and separation costs | 203 | 90 | 19 | 193 | 81 | |
| Equity in (loss) earnings of nonconsolidated affiliates | −7 | −6 | 1 | 75 | 85 | |
| Sundry income (expense) - net | 14 | −111 | 80 | 191 | 145 | |
| Interest expense | 313 | 366 | 396 | 492 | 525 | |
| Income (loss) from continuing operations before income taxes | 200 | 117 | −279 | 1,448 | 1,444 | |
| Provision for (benefit from) income taxes on continuing operations | 102 | 213 | −217 | 387 | 237 | |
| Income (loss) from continuing operations, net of tax | 98 | −96 | −62 | 1,061 | 1,207 | |
| (Loss) income from discontinued operations, net of tax | −836 | 834 | 524 | 4,856 | 5,308 | |
| Net (loss) income | −738 | 738 | 462 | 5,917 | 6,515 | |
| Net income attributable to noncontrolling interests | 41 | 35 | 39 | 49 | 48 | |
| Net (loss) income available for DuPont common stockholders | −779 | 703 | 423 | 5,868 | 6,467 | |
| Earnings (loss) per common share from continuing operations - basic (in USD per share) | 0.21 | −0.23 | −0.15 | 2.02 | 2.17 | |
| (Loss) earnings per common share from discontinued operations - basic (in USD per share) | −2.08 | 1.91 | 1.09 | 9.75 | 9.75 | |
| (Loss) earnings per common share - basic (in USD per share) | −1.87 | 1.68 | 0.94 | 11.77 | 11.92 | |
| Earnings (loss) per common share from continuing operations - diluted (in USD per share) | 0.21 | −0.23 | −0.15 | 2.02 | 2.16 | |
| (Loss) earnings per common share from discontinued operations - diluted (in USD per share) | −2.07 | 1.91 | 1.09 | 9.73 | 9.72 | |
| (Loss) earnings per common share - diluted (in USD per share) | −1.86 | 1.68 | 0.94 | 11.75 | 11.89 | |
| Weighted-average common shares outstanding - basic (in shares) | 418 | 419 | 450 | 499 | 543 | |
| Weighted-average common shares outstanding - diluted (in shares) | 419 | 419 | 450 | 499 | 544 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 715 | 1,792 | 2,392 | 3,662 | 1,972 | |
| Restricted cash and cash equivalents | 42 | 6 | 411 | 7 | — | |
| Accounts and notes receivable - net | 1,669 | 1,342 | 2,370 | 2,518 | 2,159 | |
| Inventories | 1,172 | 1,130 | 2,147 | 2,329 | 2,086 | |
| Prepaid and other current assets | 121 | 125 | 194 | 161 | 177 | |
| Assets of discontinued operations | 1,856 | 16,380 | 0 | 1,291 | 7,664 | |
| Total current assets | 5,575 | 20,775 | 7,514 | 11,270 | 14,303 | |
| Property, plant and equipment | 7,029 | 6,931 | 10,725 | 10,179 | 9,895 | |
| Less: Accumulated depreciation | 3,565 | 3,477 | 4,841 | 4,448 | 4,142 | |
| Total property, plant and equipment net | 3,464 | 3,454 | 5,884 | 5,731 | 5,753 | |
| Goodwill | 7,915 | 7,561 | 7,657 | 16,663 | 16,981 | |
| Other intangible assets | 2,936 | 3,178 | 5,814 | 5,495 | 6,222 | |
| Restricted cash and cash equivalents - noncurrent | 0 | 36 | 0 | 103 | 53 | |
| Investments and noncurrent receivables | 432 | 418 | 1,071 | 733 | 919 | |
| Deferred income tax assets | 282 | 237 | 312 | 109 | 116 | |
| Deferred charges and other assets | 971 | 977 | 1,237 | 1,251 | 1,360 | |
| Total other assets | 12,536 | 12,407 | 25,154 | 24,354 | 25,651 | |
| Total Assets | 21,575 | 36,636 | 38,552 | 41,355 | 45,707 | |
| Short-term borrowings | 60 | 1,848 | 0 | 300 | 150 | |
| Accounts payable | 995 | 1,054 | 1,675 | 2,103 | 2,102 | |
| Income taxes payable | 54 | 79 | 154 | 233 | 201 | |
| Accrued and other current liabilities | 882 | 784 | 1,269 | 951 | 1,040 | |
| Liabilities of discontinued operations | 314 | 1,731 | 0 | 146 | 1,413 | |
| Total current liabilities | 2,305 | 5,496 | 3,098 | 3,733 | 4,931 | |
| Long-Term Debt | 3,134 | 5,323 | 7,800 | 7,774 | 10,632 | |
| Deferred income tax liabilities | 405 | 524 | 1,130 | 1,158 | 1,459 | |
| Pension and other post-employment benefits - noncurrent | 432 | 432 | 565 | 522 | 762 | |
| Other noncurrent obligations | 1,196 | 1,068 | 1,234 | 1,151 | 873 | |
| Total other noncurrent liabilities | 2,033 | 2,024 | 2,929 | 2,831 | 3,094 | |
| Total Liabilities | 7,472 | 12,843 | 13,827 | 14,338 | 18,657 | |
| Commitments and contingent liabilities | — | — | — | — | — | |
| Common stock (authorized 1,666,666,667 shares of $0.01 par value each; issued 2025: 409,195,445 shares; 2024: 417,994,343 shares) | 4 | 4 | 4 | 5 | 5 | |
| Additional paid-in capital | 38,718 | 47,922 | 48,059 | 48,420 | 49,574 | |
| Accumulated deficit | −24,278 | −23,076 | −22,874 | −21,065 | −23,187 | |
| Accumulated other comprehensive loss | −525 | −1,500 | −910 | −791 | 41 | |
| Total DuPont stockholders' equity | 13,919 | 23,350 | 24,279 | 26,569 | 26,433 | |
| Noncontrolling interests | 184 | 443 | 446 | 448 | 617 | |
| Total equity | 14,103 | 23,793 | 24,725 | 27,017 | 27,050 | |
| Total Liabilities and Equity | 21,575 | 36,636 | 38,552 | 41,355 | 45,707 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 647 | 635 | 580 | 1,135 | 1,112 | |
| Provision (credit) for deferred income tax and other tax related items | 13 | −92 | −308 | −157 | −252 | |
| Earnings of nonconsolidated affiliates less than (in excess of) dividends received | 8 | 5 | −2 | 36 | 12 | |
| Net periodic pension benefit cost (credit) | 3 | −1 | 23 | 2 | 3 | |
| Periodic benefit plan contributions | −44 | −43 | −49 | −66 | −74 | |
| Net gain on assets, businesses and investments | −3 | −4 | −11 | −78 | −171 | |
| Restructuring and asset related charges - net | 151 | 57 | 99 | 155 | 50 | |
| Stock based compensation | 38 | 56 | 57 | 75 | — | |
| Loss on debt extinguishment | 99 | 74 | 0 | 0 | — | |
| Interest rate swap (gain) loss | −31 | 138 | 0 | 0 | — | |
| Interest rate swap termination | −123 | 0 | 0 | — | — | |
| Donatelle contingent earn-out true-up | −19 | 0 | 0 | — | — | |
| Other net loss (income) | 36 | −23 | 57 | −59 | 177 | |
| Accounts and notes receivable | −201 | −83 | 163 | −79 | −346 | |
| Inventories | −10 | 61 | 117 | −215 | −248 | |
| Accounts payable | 61 | −36 | −232 | −138 | 221 | |
| Other assets and liabilities, net | −163 | 117 | −255 | −423 | 143 | |
| Cash provided by operating activities - continuing operations | 560 | 765 | 845 | 1,249 | 1,846 | |
| Capital expenditures | −333 | −285 | −302 | −662 | −788 | |
| Proceeds and adjustments to proceeds from sales of property and businesses, net of cash divested | 0 | −7 | 1,236 | 10,951 | 797 | |
| Acquisitions of property and businesses, net of cash acquired | −55 | −313 | −1,761 | 5 | −2,346 | |
| Purchases of investments | 0 | 0 | −32 | −1,317 | −2,001 | |
| Proceeds from sales and maturities of investments | 0 | 0 | 1,334 | 15 | 2,001 | |
| Other investing activities, net | 14 | 43 | 6 | 12 | 39 | |
| Cash (used for) provided by investing activities - continuing operations | −374 | −562 | 481 | 9,004 | −2,298 | |
| Changes in short-term borrowings | 60 | 0 | 0 | −150 | 150 | |
| Distribution from Electronics at spin-off | 4,100 | 0 | 0 | — | — | |
| Payments on long-term debt and fees | −4,134 | −687 | −300 | — | — | |
| Purchases of common stock and forward contracts | −500 | −500 | −2,000 | −4,375 | −2,143 | |
| Proceeds from issuance of Company stock | 32 | 50 | 27 | 88 | 115 | |
| Employee taxes paid for share-based payment arrangements | −26 | −27 | −27 | −27 | −26 | |
| Distributions to noncontrolling interests | −9 | −5 | −4 | −26 | −29 | |
| Dividends paid to stockholders | −597 | −635 | −651 | −652 | −630 | |
| Cash transferred to Electronics at spin-off | −664 | 0 | 0 | — | — | |
| Payment of excise tax on purchase of treasury stock | −8 | −21 | 0 | 0 | — | |
| Other financing activities, net | −4 | −1 | −1 | −4 | −26 | |
| Cash used for financing activities - continuing operations | −1,750 | −1,826 | −2,956 | −7,646 | −7,589 | |
| Cash provided by operations - discontinued operations | 852 | 1,082 | 1,073 | −661 | 435 | |
| Cash used for investing activities - discontinued operations | −313 | −287 | −342 | −81 | −103 | |
| Cash used for financing activities - discontinued operations | −118 | −21 | −33 | −21 | 1,082 | |
| Cash provided by discontinued operations | 421 | 774 | 698 | −763 | 1,414 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 11 | −62 | −36 | −148 | −72 | |
| Decrease in cash, cash equivalents and restricted cash | −1,132 | −911 | −968 | 1,696 | −6,699 | |
| Interest, net of amounts capitalized - from continuing operations | 362 | 394 | 408 | 494 | 497 | |
| Income taxes, net of refunds - from continuing operations | 127 | 184 | 168 | 642 | 433 | |
| Income taxes, net of refunds - from discontinued operations | 204 | 132 | 226 | 202 | 128 |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is DuPont de Nemours, Inc.'s CIK number?
DuPont de Nemours, Inc.'s SEC CIK number is 0001666700 (1666700). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find DuPont de Nemours, Inc.'s SEC filings?
All of DuPont de Nemours, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did DuPont de Nemours, Inc. last report earnings?
DuPont de Nemours, Inc. (DD) most recently filed an earnings 8-K with the SEC on May 5, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001666700-26-000029). This is DuPont de Nemours, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is DuPont de Nemours, Inc.'s most recent earnings 8-K?
DuPont de Nemours, Inc.'s latest earnings 8-K (Item 2.02) was filed May 5, 2026 under accession 0001666700-26-000029. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View DuPont de Nemours, Inc.'s latest earnings 8-K →
Look up any company's CIK number →